Intelligence · Clinical pipeline
Infectious disease · Approved programs
Infectious disease programs at Approved programs — ClinicalTrials.gov pipeline intelligence.
Quick answer
Infectious disease Approved programs programs: NovaPharmaNews indexes 151 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Chinese Academy of 28 programs
- Sinovac Research and 20 programs
- United Therapeutics Europe 15 programs
- BRIGHT MINDS BIOSCIENCES 14 programs
- George Institute for 13 programs
- First People's Hospital 11 programs
- Hospital Authority 7 programs
- Disc Medicine 4 programs
- GSK Glaxo Smith 4 programs
- Anaxis Pharma 2 programs
- HOFFMANN-LA ROCHE 2 programs
- Phathom Pharmaceuticals 2 programs
Pipeline programs
-
Peginterferon alfa
Third Affiliated Hospital, Sun Yat-Sen University
Chronic Hepatitis B
1 trial -
Peginterferon alfa-2a
Vera Therapeutics
Hepatitis B, Chronic
1 trial -
Pfizer-BioNTech mRNA COVID-19 vaccine
BRIGHT MINDS BIOSCIENCES INC.
COVID -19
1 trial -
Pharmacotherapy for opioid use disorder
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Pidotimod
Almirall, S.A.
Recurrent Respiratory Tract Infections
1 trial -
Pioglitazone
Takeda
Nonalcoholic Steatohepatitis
1 trial -
Prevenar 13
United Therapeutics Europe Ltd
Sepsis
1 trial -
Raltegravir
Merck KGaA, Darmstadt, Germany
Human Immunodeficiency Virus (HIV) Infection
1 trial -
Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules)
United Therapeutics Europe Ltd
Diarrhea
1 trial -
Regimen:TDF+3TC+EFV
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hiv
1 trial -
Regimen：BIC+FTC+TAF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HIV Infection
1 trial -
Renoir
The George Institute
Covid-19 infection
1 trial -
Rifaximin
United Therapeutics Europe Ltd
Clostridium Difficile Infection
1 trial -
SARS-CoV-2 Inactivated Vaccine
Sinovac Research and Development Co.,
COVID-19
2 trials -
Sertraline Hydrochloride
The First People's Hospital of Lianyungang
COVID-19 Vaccine Adverse Reaction
1 trial -
Short Cycle Antiretroviral Therapy
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
BRIGHT MINDS BIOSCIENCES INC.
HEPATITIS C (HCV)
1 trial -
Sofosbuvir/velpatasvir (Epclusa®)
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis C
1 trial -
Sulfadoxine-pyrimethamine
United Therapeutics Europe Ltd
Malaria (Uncomplicated)
1 trial -
Sulforaphane
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
HIV Infections
1 trial -
TDF
Gilead Sciences Ireland UC
Chronic Hepatitis B
1 trial -
TYRX™ Absorbable Antibacterial Envelope
Rhythm Pharmaceuticals Netherlands B.V.
CIED Related Infection
1 trial -
Telaprevir
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
11 trials -
Telbivudine treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
Tenofovir Alafenamide 25 MG
The First People's Hospital of Lianyungang
Chronic Hepatitis C
1 trial -
Tenofovir Alafenamide Tablets
The First People's Hospital of Lianyungang
Chronic Hepatitis b
1 trial -
Tenofovir Alafenamide fumarate 25mg Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
Tenofovir disoproxil fumarate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
The live attenuated varicella vaccine and the inactivated hepatitis A vaccine
Sinovac Research and Development Co.,
Varicella
1 trial -
The papillon study
Pierre Fabre Australia Pty Ltd
giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral
1 trial -
Tigecycline
Wyeth is now a wholly owned subsidiary of Pfizer
Skin Diseases, Bacterial
1 trial -
Trimebutine 100 MG
Hospital Authority, Hong Kong
Helicobacter Pylori Infection
1 trial -
Trivalent live attenuated seasonal influenza vaccine
The University of Hong Kong
Influenza Virus Infection
1 trial -
Ursodeoxycholic acid combined with total glucosides of paeony
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis
1 trial -
Vaccination to prevent hepatitis B virus infection
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis B
1 trial -
Vancomycin
The First People's Hospital of Lianyungang
Blood Stream Infections
1 trial -
Vemlidy
Hospital Authority, Hong Kong
Chronic Hepatitis b
1 trial -
Video directly observed therapy with contingency management
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Vonoprazan
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
2 trials -
Vonoprazan and Amoxicillin for the first 7 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Xuebijing Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
2 trials -
[68Ga]FAPI-46
Disc Medicine
post-acute sequelae of COVID-19
1 trial -
adefovir dipivoxil
GlaxoSmithKline
Hepatitis B, Chronic
1 trial -
albumin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
artemether lumefantrine
United Therapeutics Europe Ltd
Uncomplicated Malaria
1 trial -
artemether-lumefantrine (ALN)
United Therapeutics Europe Ltd
Uncomplicated Malaria
1 trial -
buprenorphine
Indivior Pty Ltd
Hepatitis C, Chronic
1 trial -
fluocinolone acetonide 190 micrograms
ANI PHARMACEUTICALS INC
Non-infectious Uveitis Affecting the Posterior Segment of the Eye
1 trial
Frequently asked questions
How many infectious disease Approved programs programs exist?
151 programs match both the therapeutic area and stage filters in our published index.